Loading...
XESM
MLC
Market cap157mUSD
Aug 24, Last price  
7.00EUR
Name

Malin Corporation PLC

Chart & performance

D1W1MN
XESM:MLC chart
P/E
P/S
EPS
Div yield, %
Shrs. gr., 5y
-30.51%
Rev. gr., 5y
8.79%
Revenues
Net income
CFO

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Malin Corporation plc operates as a life sciences firm across Ireland and the United States, primarily through its various subsidiaries. The company specializes in developing and delivering vital solutions for critical medical challenges. Its portfolio includes groundbreaking cell and gene therapies aimed at patients with significant unmet medical requirements. Furthermore, Malin provides treatments targeting pressing needs in oncology, infectious diseases, and autoimmune conditions. It also addresses specific women's health concerns, such as recurrent vulvovaginal candidiasis, and offers remedies for fungal nail infections like onychomycosis. Beyond these, Malin's offerings extend to pharmaceutical products for protein misfolding disorders, a sophisticated platform designed to identify pathogenic bacteria within the gut microbiome, and advanced UV-light disinfection technologies. Additionally, it offers corporate secretarial services. Established in 2014, Malin Corporation plc maintains its headquarters in Dublin, Ireland.
IPO date
Mar 25, 2015
Employees
Domiciled in
IE
Incorporated in
IE

Valuation

No data to show